Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 14.19B | 14.27B | 14.00B | 15.48B | 35.71B |
Gross Profit | 6.17B | 6.70B | 6.28B | 6.95B | 8.16B |
EBITDA | -57.72M | 1.89B | 1.02B | 539.39M | 2.13B |
Net Income | -530.40M | 1.01B | 254.88M | 310.44M | 1.43B |
Balance Sheet | |||||
Total Assets | 29.53B | 27.08B | 25.41B | 25.09B | 27.07B |
Cash, Cash Equivalents and Short-Term Investments | 10.10B | 12.86B | 14.31B | 13.77B | 17.97B |
Total Debt | 17.11B | 11.66B | 9.47B | 10.26B | 11.55B |
Total Liabilities | 20.20B | 16.28B | 15.44B | 15.44B | 17.33B |
Stockholders Equity | 9.20B | 10.66B | 9.80B | 9.39B | 9.21B |
Cash Flow | |||||
Free Cash Flow | -1.20B | -424.17M | 1.56B | 38.14M | 2.31B |
Operating Cash Flow | -1.14B | -385.00M | 1.59B | 683.15M | 2.43B |
Investing Cash Flow | -6.59B | -1.64B | -708.65M | -1.28B | 72.71M |
Financing Cash Flow | 4.63B | 572.01M | -345.60M | -692.96M | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥6.79B | 22.71 | ― | 12.30% | -103.84% | ||
71 Outperform | ¥6.17B | 51.62 | ― | 13.48% | 49.30% | ||
67 Neutral | ¥4.73B | 47.99 | ― | 51.83% | -62.04% | ||
66 Neutral | ¥6.74B | 70.07 | ― | 14.20% | -57.38% | ||
63 Neutral | ¥7.23B | ― | ― | -6.68% | -255.00% | ||
62 Neutral | £505.62M | 27.06 | 0.85% | 2.79% | 3.88% | -21.08% | |
57 Neutral | ¥7.37B | 7.34 | 3.90% | -25.27% | ― |